Cargando…
Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against Helicobacter pylori in a Mouse Model
Helicobacter pylori eradication rate with conventional standard therapy is decreasing owing to antibiotic resistance, necessitating novel antibacterial strategies against H. pylori. We evaluated the efficacy of a gentamicin-intercalated smectite hybrid (S-GM)-based treatment and analyzed fecal micro...
Autores principales: | Jeong, Su Jin, Lee, Kyoung Hwa, Kim, Jie-Hyun, Park, Soon Young, Song, Young Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460432/ https://www.ncbi.nlm.nih.gov/pubmed/32785101 http://dx.doi.org/10.3390/antibiotics9080502 |
Ejemplares similares
-
2449. Validation of In Vitro Activity of Aminoglycosides Against Recently Isolated Helicobacter pylori for Commercialization of Gentamicin-Intercalated Smectite Hybrid as a New Therapeutic Agent
por: Lee, Kyoung Hwa, et al.
Publicado: (2018) -
Intercalated theophylline-smectite hybrid for pH-mediated delivery
por: Trivedi, Vivek, et al.
Publicado: (2018) -
Can Aminoglycosides Be Used as a New Treatment for Helicobacter pylori? In vitro Activity of Recently Isolated Helicobacter pylori
por: Lee, Kyoung Hwa, et al.
Publicado: (2019) -
Intercalation and Retention of Carbon Dioxide in a Smectite Clay promoted by Interlayer Cations
por: Michels, L., et al.
Publicado: (2015) -
Helicobacter pylori Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis
por: Yang, Lu, et al.
Publicado: (2019)